1-2 of 2
Josep Nomdedeu
Close
Sort by
Journal Articles

Engraftment characterization of risk-stratified AML in NSGS mice

Rafael Díaz de la Guardia, Talía Velasco-Hernandez, Francisco Gutiérrez-Agüera, Heleia Roca-Ho, Oscar Molina, Cesar Nombela-Arrieta, Alex Bataller, Jose Luis Fuster, Eduardo Anguita, Susana Vives, Lurdes Zamora, Josep Nomdedeu, María Teresa Gómez-Casares, Manuel Ramírez-Orellana, Helene Lapillonne, Verónica Ramos-Mejia, Juan Carlos Rodríguez-Manzaneque, Clara Bueno, Belen Lopez-Millan, Pablo Menéndez
Journal: Blood Advances
Blood Adv (2021) 5 (23): 4842–4854.
https://doi.org/10.1182/bloodadvances.2020003958
Published: 2021
Includes: Multimedia, Supplemental data
Journal Articles

Midostaurin in patients with acute myeloid leukemia and FLT3 -TKD mutations: a subanalysis from the RATIFY trial

Clinical Trials & Observations
Maria Teresa Voso, Richard A. Larson, Dan Jones, Guido Marcucci, Thomas Prior, Jürgen Krauter, Michael Heuser, Serena Lavorgna, Josep Nomdedeu, Susan M. Geyer, Alison Walker, Andrew H. Wei, Jorge Sierra, Miguel A. Sanz, Joseph M. Brandwein, Theo M. de Witte, Joop H. Jansen, Dietger Niederwieser, Frederick R. Appelbaum, Bruno C. Medeiros, Martin S. Tallman, Richard F. Schlenk, Arnold Ganser, Sergio Amadori, Yuan Cheng, YinMiao Chen, Celine Pallaud, Ling Du, Alfonso Piciocchi, Gerhard Ehninger, John Byrd, Christian Thiede, Konstanze Döhner, Richard M. Stone, Hartmut Döhner, Clara D. Bloomfield, Francesco Lo-Coco
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4945–4954.
https://doi.org/10.1182/bloodadvances.2020002904
Published: 2020
Includes: Supplemental data